Ann Lee-Karlon, Ph.D., is CEO, President, and Board member of EpiBiologics. She previously served as Chief Operating Officer of Altos Labs, where she was instrumental in building the foundation for rapid growth to 500 employees across 3 global sites. Prior to Altos, Ann spent over 18 years at Genentech, most recently as Senior Vice President. She led portfolio strategy and operations and had project leadership oversight for over 80 drug development teams from R&D through FDA approval and global launch, including major partnerships and programs, including Ocrevus for MS and Rituxan in immunology. Before Genentech, Ann served in the new ventures group at Lilly. Ann holds a BS in bioengineering from UC Berkeley, MBA from Stanford University, and PhD in bioengineering from UC San Diego, where she was a National Science Foundation Fellow. Ann was the president and board chair of the Genentech Patient Foundation and president and board chair of the Association for Women in Science, based in Washington, D.C. She is a board member of Eko Health and serves on advisory boards for UC Berkeley and UCSD. Ann was elected Fellow of the American Institute for Medical and Biological Engineering and is a Fellow of the Aspen Institute.